Stockreport

4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT's Therapeutic Vector Evolution platform to invent potentially best-in-clas [Read more]